Skip to main content
Premium Trial:

Request an Annual Quote

Ricardo Macarron, Cheri Walker, Gregg Fergus

Premium
Ricardo Macarron has been named president of the Society for Biomolecular Sciences.
 
Macarron, vice president of compound management at GlaxoSmithKline, was an SBS board member and is an editor of the SBS’ Journal of Biomolecular Screening.
 

 
Charles River Laboratories International has appointed Cheri Walker to the post of corporate senior vice president of corporate development.
 
Before coming to Charles River, Walker was vice president of mergers and acquisitions for Qiagen and worked in corporate development and in operations at Invitrogen.
 

 
Gregg Fergus has joined NimbleGen’s board of directors, the company said last week.
 
Fergus formerly was senior vice president of sales and global operations at Affymetrix and was CCO at Cellular Dynamics and Stem Cell Products.
 
Fergus also has consulted for Caden Biosciences and was an executive in residence at Baird Venture Partners.

Filed under

The Scan

Vaccine Update Recommended

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

US to Make More Vaccines for Monkeypox Available

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

Sentence Appealed

The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.

Genome Biology Papers on COVID-19 Effector Genes, Virtual ChIP-seq, scDART

In Genome Biology this week: proposed COVID-19 effector genes, method to predict transcription factor binding patterns, and more.